Association of 2238T>C Polymorphism of the Atrial Natriuretic Peptide Gene With Coronary Artery Disease in Afro-Caribbeans With Type 2 Diabetes
Open Access
- 1 May 2012
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 25 (5) , 524-527
Abstract
Background. The atrial natriuretic peptide (ANP) is known mainly for its effects on kidney function and blood pressure homeostasis. We investigated theKeywords
This publication has 14 references indexed in Scilit:
- Genetic Polymorphisms of the Natriuretic Peptide System in the Pathogenesis of Cardiovascular Disease: What Lies on the Horizon?Clinical Chemistry, 2009
- Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular DiseasesAmerican Journal of Hypertension, 2008
- Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart FailureClinical Chemistry, 2007
- An Unsuspected Metabolic Role for Atrial Natriuretic PeptidesArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Vasoprotective Actions of the Atrial Natriuretic PeptideCurrent Medicinal Chemistry-Cardiovascular & Hematological Agents, 2005
- Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in HumansStroke, 2004
- Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery diseaseAmerican Heart Journal, 2003
- Genetic analysis of the atrial natriuretic peptide gene in essential hypertensionClinical Science, 2000
- Polymorphisms within the atrial natriuretic peptide gene in essential hypertensionJournal Of Hypertension, 1995
- Physiologic and Pharmacologic Studies of Atrial Natriuretic Factor: A Natriuretic and Vasoactive PeptideThe Journal of Clinical Pharmacology, 1987